Compulsivity is a key manifestation of inhibitory control deficit and a cardinal symptom of psychopathological conditions such as obsessive-compulsive and attention-deficit hyperactivity disorders, in which metabolic alterations have raised attention as putative biomarkers for early identification. The present study assessed the metabolic profile in a preclinical model of a compulsive phenotype of rats. We used the schedule-induced polydipsia (SIP) method to classify male Wistar rats into high drinkers (HDs) or low drinkers (LDs) according to their compulsive drinking rate developed by exposure to a fixed-time 60 s (FT-60) schedule of reinforcement with water available ad libitum during 20 sessions. Before and after SIP, blood samples were collected for subsequent serum analysis by nuclear magnetic resonance spectroscopy coupled to multivariate analysis. Although no differences existed in the pre-SIP set, the compulsive drinking behavior induced remarkable metabolic alterations: HD rats selected by SIP exhibited a hyperlipidemic, hypoglycemic, and hyperglutaminergic profile compared with their low-compulsive counterparts. Interestingly, these alterations were not attributable to the mere exposure to reward pellets because a control experiment did not show differences between HDs and LDs after 20 sessions of pellet consumption without intermittent reinforcement. Our results shed light toward the implication of dietary and metabolic factors underpinning the vulnerability to compulsive behaviors.
Compulsivity is a key manifestation of inhibitory control deficit and a cardinal symptom of psychopathological conditions such as obsessive-compulsive and attention-deficit hyperactivity disorders, in which metabolic alterations have raised attention as putative biomarkers for early identification. The present study assessed the metabolic profile in a preclinical model of a compulsive phenotype of rats. We used the schedule-induced polydipsia (SIP) method to classify male Wistar rats into high drinkers (HDs) or low drinkers (LDs) according to their compulsive drinking rate developed by exposure to a fixed-time 60 s (FT-60) schedule of reinforcement with water available ad libitum during 20 sessions. Before and after SIP, blood samples were collected for subsequent serum analysis by nuclear magnetic resonance spectroscopy coupled to multivariate analysis. Although no differences existed in the pre-SIP set, the compulsive drinking behavior induced remarkable metabolic alterations: HD rats selected by SIP exhibited a hyperlipidemic, hypoglycemic, and hyperglutaminergic profile compared with their low-compulsive counterparts. Interestingly, these alterations were not attributable to the mere exposure to reward pellets because a control experiment did not show differences between HDs and LDs after 20 sessions of pellet consumption without intermittent reinforcement. Our results shed light toward the implication of dietary and metabolic factors underpinning the vulnerability to compulsive behaviors.
Compulsivity is defined as a perseveration of a response that is
irresistible, inappropriate, and unavoidable despite its negative
consequences.[1] It is the core feature observed
in obsessive-compulsive disorder (OCD), although it is present in
other neuropsychopathological conditions such as schizophrenia, autism,
attention-deficit hyperactivity disorder, and addiction.[2−4] These are considered as impulsive compulsive spectrum disorders,
with a high prevalence (1–3%) in Western countries and an approximate
economic cost of $5 billion per year according to the World Health
Organization.[5] However, little is known
about the relation between metabolic factors and inhibitory control
deficit. Research on the possible identification of metabolic biomarkers
underlying inhibitory control deficit and the effect of diet on the
nervous system and behavior could help scientists and physicians to
improve their knowledge about new mechanisms for prevention and treatment
in psychopathological disorders.Metabolomics has been widely
applied in biomedicine to provide
a precise analysis of small molecules (<1500 Da) associated with
human metabolism. Unlike DNA, RNA, or proteins, metabolites can accurately
reflect the most direct metabolic changes in our body under a certain
condition in a short time period and are thus good indicators of the
onset and progression of human diseases.[6] So, the analysis of metabolites represents a sensitive measure of
biological status in health or under disease.[7] Nuclear magnetic resonance (NMR) spectroscopy offers the unique
prospect to holistically screen several metabolites with a non-a-priori selection in diverse matrices
as biological fluids and even in tissue biopsies.[8] NMR-based metabolomics analysis coupled to multivariate
statistical techniques have been incorporated into agricultural culture
programs and clinical disease research to identify unique metabolite
biomarkers in the quest for nutritional or organoleptic advantages
or in a specific human disease, respectively. When the focus is placed
on the identification of disease-associated biomarkers, this could
allow us to (1) predict and diagnose diseases and their stages, (2)
provide insights into underlying pathways in the pathogenesis and
progression of the diseases, and (3) aid in disease treatment by assessing
the efficacy and mechanism of action of therapeutic solutions.[6,9]The use of animal models with higher translational power,
associated
with neurobehavioral endophenotypes based on biomarkers, has enabled
us to bridge the gap between (dys)functional neuronal circuits and
psychological constructs with bigger predictive strength than the
current psychiatric nosology.[10] However,
to the best of our knowledge, only a few studies have investigated
metabolomic biomarkers in animal models. In a recent study, Perez-Fernandez
et al.[11] found a hyperlipidemic and hypoglycemic
profile in animals exposed to Chlorpyrifos, which also showed behavioral
alterations, that is, impairments in the reaction to social novelty
in the Crawley social test.Schedule-induced polydipsia (SIP)
is one of the most well-established
preclinical models for the study of neuropsychopathological disorders
presenting compulsive behavior, such as OCD, schizophrenia, and alcohol
abuse. (For a review, see Moreno and Flores).[12] The SIP procedure is characterized by the development of an adjunctive
behavior of excessive and persistent drinking, which is nonregulatory
and does not rely on physiological demands, in food-deprived animals
exposed to intermittent food-reinforcement schedules in operant chambers
with water available ad libitum.[13,14] However, there are important individual differences in the development
of adjunctive drinking after 15–20 sessions in SIP. Rats can
be separated into two groups according to their rates of drinking,
one with high or compulsive drinking (HD rats) and a second group
with low drinking or no SIP acquisition (LD rats). This phenomenon
resembles the key features of human compulsivity and OCD, thus allowing
us to identify vulnerable populations based on their endophenotype
(for a review, see Moreno and Flores)[12] and entailing an outstanding chance of studying compulsive behavior
under laboratory conditions.In this sense, the promising role
of metabolism as a putative contributing
factor concerning vulnerability to inhibitory control deficit necessitates
further research; specifically, the use of biomarkers for the early
identification of such conditions creates the context for a better
understanding of the problem and for early detection and, in the future,
early intervention. The present study aims to add evidence in that
direction with the aid of SIP.
Materials and Methods
Subjects
Forty male Wistar rats (Envigo,
Spain) were used in this study (40 for the SIP experiment, 20 of them
for the control experiment) and arrived at the laboratory weighing
200–250 g. They were housed in a four rats per cage (50 ×
35 × 20 cm) distribution at a temperature of 22 ± 1 °C
with a 12:12 h light–dark cycle with lights off at 08:00 h.
They also had environmental enrichment consisting of PVC pipe tubes
and wooden blocks and food and water provided ad libitum. Before SIP, the animals’ bodyweights were gradually reduced
to 85% of their free-feeding baseline level through controlled feeding
and daily weighing and then maintained throughout the experiment.
Food, consisting of lab chow, was provided daily ∼30 min after
each experimental session. All of the testing occurred between 9:00
am and 2:00 pm. All procedures were in accordance with the Spanish
Royal Decree 53/2013 on the protection of experimental animals and
the European Directive 2010/63/EU and approved by the Animal Research
Committee of the University of Almería. We declare that the
research shows commitment to the 3Rs principle (replacement, reduction,
refinement).
Experimental Design
Once all animals
reached 85% bodyweight compared with their baseline, blood samples
(pre-SIP) were taken (see as follows) on the day before the start
of the SIP procedure. Then, after SIP, post-SIP samples were collected.
After 1 month of washout (based on previous publications; see Mora
et al.),[15] half of the animals were selected
for a control test concerning the dietary impact on their metabolism.
Blood samples were collected before (pre-pellet) and after (post-pellet)
exposure to the test pellets with water available ad libitum. Figure shows the
experimental timeline of relevant events.
Figure 1
Experimental procedure
illustrated in a timeline. After habituation
to the lab, animals were divided into high drinkers (HDs) and low
drinkers (LDs) by schedule-induced polydipsia (SIP) before (pre-SIP)
and after (post-SIP) blood samples were taken. After SIP, animals
remained undisturbed for 1 month. Then, an additional experiment regarding
exposure to reward pellets took place to assess its dietary impact
on metabolomic analyses; again, blood samples were collected before
(pre-pellet) and after (post-pellet) exposure.
Experimental procedure
illustrated in a timeline. After habituation
to the lab, animals were divided into high drinkers (HDs) and low
drinkers (LDs) by schedule-induced polydipsia (SIP) before (pre-SIP)
and after (post-SIP) blood samples were taken. After SIP, animals
remained undisturbed for 1 month. Then, an additional experiment regarding
exposure to reward pellets took place to assess its dietary impact
on metabolomic analyses; again, blood samples were collected before
(pre-pellet) and after (post-pellet) exposure.
Blood Sampling
Animals were anesthetized
using isoflurane, and blood samples (1 mL) were collected from the
lateral tail vein in 1.5 mL autocued plastic tubes between 9:00 am
and 12:00 pm (dark cycle). The samples were allowed to stand for 10
min before centrifuging (Sigma 3-18KS, Germany) at 3000 rpm (800g) for 10 min at 23 °C, after which serum was collected
into duplicate 0.5 mL autocued plastic tubes and stored at −80
°C until assay.
SIP Procedure
Rats were tested in
12 operant SIP chambers (32 × 25 × 34 cm) (MED Associates,
St. Albans, VT). A previous description of the apparatus can be found
in Moreno et al.[16] Programming and data
recording were performed with the aid of a computer and commercial
software Med PC (Cibertec SA, Spain). Prior to SIP, two baseline water
ingestion tests on successive days were performed, where the amount
(in mL) of water consumed by each animal during a period of time of
60 min with free access to 60 pellets (Noyes 45 mg dustless reward
pellets; TSE Systems, Germany) was measured. After 1 day of habituation
to the chambers session, rats underwent 60 min daily sessions of a
fixed-time 60 s (FT-60s) schedule of food pellet delivery, where bottles
containing freshwater ad libitum were placed in the
wall opposite to the pellet dispenser. Measures recorded were: (1)
total amount of water (in mL) consumed, (2) total number of licks
to the bottle, and (3) total number of food magazine entries. After
19 daily sessions of SIP acquisition, animals were selected in two
groups, high and low drinkers (HDs and LDs, n = 20
in each group), according to if their drinking rates during SIP (average
of water intake on the last five sessions) were above or below the
group median, respectively.
Exposure to Diet Pellets
Half of
the animals of each group (HD and LD, n = 10 in each
group) were exposed to 19 consecutive exposure sessions similar to
SIP to further assess any dietary impact of the reward pellets. The
animals received the same number of pellets as during the SIP procedure
(60 pellets), but in this case, the pellets were presented under mass
feeding conditions without a food-reinforcement time schedule; water
was available ad libitum. As in SIP, the consumption
of all pellets was assured by the experimenters after each session.
Sample Preparation for NMR
For NMR
experiments, 150 μL of rat blood serum was mixed with 350 μL
of D2O containing 0.9% NaCl and the sodium salt of 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid (TSP) at 0.01% (w/w). The resulting mixture
was vortexed and centrifuged for 5 min at 13 500 rpm, and 500
μL of supernatants was transferred into oven-dried 5 mm NMR
tubes.
NMR Experiments
Acquisition of 1H NMR spectra of serum samples was conducted as described
by Perez-Fernandez et al.[11] with some modifications.
Measurements were carried out on a Bruker Avance III 600 spectrometer
operating at 600.13 MHz, equipped with a 5 mm QCI quadruple resonance
pulse field gradient cryoprobe and a SampleJet autosampler, at 293
± 0.1 K and without rotation. The water-suppressed Carr–Purcell–Meibom–Gill
(CPMG) pulse sequence was applied with a total spin echo delay of
100 ms (τ – 180° – τ, 400 μs
– 37 μs – 400 μs) to attenuate broad signals
from protein signals. The spectrometer transmitter was locked to D2O frequency. Acquisition parameters were set as follows: NS
= 60, DS = 16, size of fid = 32K, spectral width = 22.0 ppm, acquisition
time = 1.24 s, relaxation delay = 3 s, number of loops = 120, line
broadening = 0.3 Hz, receiver gain = 203. Spectra were automatically
phased, baseline-corrected, and calibrated to TSP signal at 0.0 ppm.
Acquisition and processing of NMR spectra were carried out by the
TOPSPIN software (version 3.6.2). Metabolite assignments were performed
thanks to information on scalar couplings extracted from 1H–1H COSY, 1H–1H TOCSY, 1H–13C HSQC, and 1H–13C HMBC spectra, which were recorded using standard Bruker
sequences, and with the help of the Chenomx database (Chenomx, Edmonton,
Canada), public NMR databases (HMDB), and literature.[17−19] Quantification of metabolites was achieved through the integrated
values of the related peak areas of nonoverlapped signals in relation
to the inner standard (TSP).
Quantification of Fatty
Acids
After
NMR acquisition, serum samples were freeze-dried for 72 h. Then, the
fatty acid content and profile in serum samples and also in the pellets
were determined by gas chromatography (Agilent Technologies 6890 N
Series Gas Chromatograph, Santa Clara, CA) after direct transesterification,
as described by Rodríguez-Ruiz et al.[20]
Statistical Data Analysis
SIP acquisition
data were analyzed using two-way repeated-measures analysis of variance
(ANOVA) with between-subject factor (group: HD and LD) and within-subject
factor (session: 19 sessions). Post hoc comparisons
were performed using the Bonferroni correction. The statistical significance
was set at p < 0.05, and the effect size was reported
when appropriate: Partial η2 values are reported
and considered as small (0.01), medium (0.06), or large (0.14) following
Cohen[21] recommendations. All analyses were
carried out using Statistica software (Statsoft, version 6.0).With respect to chemometrics analyses of 1H NMR spectral
data, AMIX 3.9.15 (Bruker BioSpin) software was used for bucketing
NMR spectra using two types of bucketing processes: (1) regular bucketing
employing a bucket size of 0.04 ppm and (2) variable bucketing of
NMR peaks assigned to specific metabolites (for univariate statistical
analyses). In both cases, normalization was achieved by scaling the
intensity of individual peaks to the total intensity recorded in the
region from δH 0.2 to 10.0 ppm, except for the region
of δH 5.2 to 4.74 ppm containing the residual signal
of H2O, which was removed. NMR regular bucketed data was
investigated by means of principal component analysis (PCA) in exploratory
studies and by partial least-squares discriminant analysis (PLS-DA)
or orthogonal partial least-squares discriminant analysis (OPLS-DA)
to determine the existence of differences between experimental groups
and to identify the metabolic features responsible for their discrimination.
This multivariate data analysis was performed using SIMCA-P software
(v. 17.0, Umetrics). The results of the cross-validation for PLS-DA
and OPLS-DA models are given by means of cumulative R2 and Q2 values, where Q2 values of >0.5 were considered indicative
of a good predictive model. Models were also validated by being subsequently
subjected to permutation tests (a total of 100), and the new coefficients R2 and Q2 generated
from the permutation test were compared with those from the real model.
If intercept R2 and Q2 values from the permutation test were significantly
smaller than Q2 of the real model, then
the model was regarded as predictable. The statistical significance
of the estimated predictive power of PLS-DA and OPLS-DA models was
further assessed with an ANOVA test of the cross-validated residuals
(cv-ANOVA). Models with p values of <0.05 were
considered to have a good prediction.Important loadings (spectral
regions) for the discrimination observed
from the predictive models were selected by generating the variable
importance in projection (VIP) plot. Loadings with VIP scores of >1
were considered relevant to the generated PLS-DA and OPLS-DA models.
ANOVA (analysis of variance) analyses followed by least significant
difference (LSD) post hoc tests were employed to
determine the significance of differences for the metabolite ratios
between groups; p values of <0.05 were considered
statistically significant. Finally, metabolic changes with false discovery
rate (FDR)-adjusted p values (q values)
of <0.05 were considered.
Results
and Discussion
SIP Acquisition
LD and HD behavior
is clearly evidenced by not only the water intake but also the number
of licks, as previously mentioned. Figure shows SIP acquisition and maintenance during
19 sessions. One-way repeated ANOVA measures revealed differences
in the SIP acquisition concerning water intake, as shown by the interaction
between sessions and group (interaction SIP session × group effect:
(F18, 666 = 9.146, p < 0.001, partial η2 = 0.198). This effect was also confirmed by the significant
interaction in total licks (interaction SIP session × group effect:
F18, 576 = 8.445, p < 0.001, partial η2 = 0.208).
Figure 2
Means (±SEM) for (A) water intake and (B) number
of licks
in FT-60s across 19 sessions of SIP. Statistical analyses indicated
significant differences between low drinkers (LDs, n = 20) and high drinkers (HDs, n = 20; ** p < 0.01) in both water intake and total licks. Significant
differences from session 1 were found in HDs from session 6 in water
intake (## p < 0.01) and from session 8 (### p < 0.001) onward.
Means (±SEM) for (A) water intake and (B) number
of licks
in FT-60s across 19 sessions of SIP. Statistical analyses indicated
significant differences between low drinkers (LDs, n = 20) and high drinkers (HDs, n = 20; ** p < 0.01) in both water intake and total licks. Significant
differences from session 1 were found in HDs from session 6 in water
intake (## p < 0.01) and from session 8 (### p < 0.001) onward.A post hoc comparison revealed that SIP induced
different drinking behaviors across the 19 sessions in high and low
drinkers: LD and HD animals exhibited remarkable differences in water
intake from session 6 (p < 0.01) onward. Moreover,
when compared with session 1, the HD group significantly increased
its water consumption from session 4 (p < 0.01)
onward. A similar pattern was found concerning total licks, where
LD and HD groups differed from session 8 (p <
0.01) onward, and HD showed an increased number of licks from session
4 (p < 0.001) onward compared with session 1.
No significant differences were found between LD and HD animals concerning
total magazine entries.
Assignment of Metabolites
in Blood Serum Detected
by 1H NMR Spectroscopy
The assignment of each
metabolite present in serum samples was achieved and is illustrated
in Figure . Table S1 provides full information on chemical
shifts, multiplicity, and coupling constants for each metabolite or
for each metabolite-type compound.
Figure 3
Subregions of a typical 1H
NMR spectrum (600 MHz) of
a blood serum sample taken to a rat from pre-SIP group. Numeration: 1: LDL/VLDL, 2: fatty acids (FA), 3: leucine, 4: isoleucine, 5: valine, 6: 3-hydroxybutyrate (3HB), 7: EtOH, 8: lactate, 9: alanine, 10: lysine, 11: acetate, 12: glutamate, 13:
glutamine, 14: acetoacetate, 15: pyruvate, 16: citrate, 17: PUFA, 18: aspartate, 19: creatine, 20: choline, 21: trimethylamine N-oxide (TMAO), 22: glycerol, 23: glucose, 24: UFA, 25: pyrimidine, 26: fumarate, 27: tyrosine, 28:
histidine, 29: phenylalanine, 30: formate.
Subregions of a typical 1H
NMR spectrum (600 MHz) of
a blood serum sample taken to a rat from pre-SIP group. Numeration: 1: LDL/VLDL, 2: fatty acids (FA), 3: leucine, 4: isoleucine, 5: valine, 6: 3-hydroxybutyrate (3HB), 7: EtOH, 8: lactate, 9: alanine, 10: lysine, 11: acetate, 12: glutamate, 13:
glutamine, 14: acetoacetate, 15: pyruvate, 16: citrate, 17: PUFA, 18: aspartate, 19: creatine, 20: choline, 21: trimethylamine N-oxide (TMAO), 22: glycerol, 23: glucose, 24: UFA, 25: pyrimidine, 26: fumarate, 27: tyrosine, 28:
histidine, 29: phenylalanine, 30: formate.The assigned metabolites belong mostly to the classes
of amino
acids (valine, isoleucine, leucine, alanine, lysine, glutamate, glutamine,
aspartate, tyrosine, and phenylalanine) and derivatives (e.g., 3-hydroxybutyrate,
creatine), organic acids (acetic acid, acetoacetic acid, citric acid,
and pyruvic acid), carbohydrates (α- and β-glucose), choline
(Cho)-based compounds, which are essential components of cellular
membranes, polyols (e.g., glycerol), and fatty acids. Trimethylamine N-oxide is an osmolyte used by the body to counteract the
effects of increased urea concentration that accumulates during kidney
failure and was also found in the spectra. Ketone bodies like 3-hydroxybutyrate,
acetate, and acetoacetate, generally induced by fasting,[17] could also be found in rat serum samples.
Chemometrics Analyses of 1H NMR
Spectral Data
Multiparametric statistical tools were applied
to NMR data in the analyses of rats serum samples to evaluate changes
in the metabolic profiles in the presence of OCD. Blood samples were
taken at four different times during the experiment: pre- and post-SIP
and pre- and post-pellet (as indicated in Figure ). An exploratory analysis of NMR data was
first achieved by means of PCA that clustered similar samples together
based on the input data (Figure S1). PCA
is useful for revealing the major trends in the 1H NMR
data and the possible analytical and biological confounder variables.
On the basis of the PCA results, a slight division of samples between
pre- and post-SIP groups (Figure S1a) and
between pre- and post-pellet groups (Figure S1b) is evident, independent of the obsessive-compulsive behavior of
the rats.
Differentiation of Pre-SIP and Post-SIP
Serum Samples
To improve the discrimination observed between
pre-SIP and post-SIP data, we applied an OPLS-DA model to the 1H NMR data (Figure A). The chosen preprocessing method contains the orthogonal
signal correction (OSC), which allows one to eliminate unnecessary
information. In the OSC procedure, the X matrix was corrected by a
subtraction of variation orthogonal to the y (containing
the classes for each sample, in this case, pre-SIP versus post-SIP)
vector calibration. The corresponding S-plot (Figure B) revealed the most relevant metabolites
for the discrimination (with VIP values >1). Metabolites of the
bottom
left were significantly decreased (alanine, lactate, unsaturated fatty
acids), whereas those located at the top right were increased post-SIP
(choline, citrate, acetate, acetoacetate, ethanol, glucose, and LDL/VLDL/saturated
fatty acids).
Figure 4
(A) OPLS-DA score plot obtained for 1H NMR
data of samples
taken prior to (n = 40) and after SIP (n = 38). (B) S-plot showing the most significant metabolites for discrimination
(metabolites with VIP > 1 values are colored): Bottom left metabolites
were significantly decreased (alanine: loadings 1.46, 1.50; lactate:
loadings 1.34, 4.14; UFA: loadings 5.34, 2.06, 2.18, 2.26, 0.94),
whereas those located at the top right were increased post-SIP (choline:
loading 3.22; citrate: loadings 2.54, 2.70; acetate: loading 1.94;
acetoacetate: loading 2.22; glucose: loadings 3.34, 3.38, 3.42, 3.46,
3.54, 3.66, 3.78, 3.82, 5.26; ethanol: loadings 1.18, 3.66; and LDL/VLDL/saturated
fatty acids: loadings 0.86, 1.26, 1.30, 2.14). Pareto scaling was
carried out. R2X = 0.639, Q2 = 0.764, p(cv-ANOVA) = 7.0
× 10–18. The model was validated by a permutation
test (with 100 permutations).
(A) OPLS-DA score plot obtained for 1H NMR
data of samples
taken prior to (n = 40) and after SIP (n = 38). (B) S-plot showing the most significant metabolites for discrimination
(metabolites with VIP > 1 values are colored): Bottom left metabolites
were significantly decreased (alanine: loadings 1.46, 1.50; lactate:
loadings 1.34, 4.14; UFA: loadings 5.34, 2.06, 2.18, 2.26, 0.94),
whereas those located at the top right were increased post-SIP (choline:
loading 3.22; citrate: loadings 2.54, 2.70; acetate: loading 1.94;
acetoacetate: loading 2.22; glucose: loadings 3.34, 3.38, 3.42, 3.46,
3.54, 3.66, 3.78, 3.82, 5.26; ethanol: loadings 1.18, 3.66; and LDL/VLDL/saturated
fatty acids: loadings 0.86, 1.26, 1.30, 2.14). Pareto scaling was
carried out. R2X = 0.639, Q2 = 0.764, p(cv-ANOVA) = 7.0
× 10–18. The model was validated by a permutation
test (with 100 permutations).The results indicate that SIP induced changes in lipid-metabolism-related
molecules (fatty acids and cholesterol levels, choline, acetate, acetoacetate,
glutamine) and energy metabolism (related to the tricarboxylic acid
(TCA) cycle). Acetate is formed in the body by the metabolism of certain
substances, in particular, in the liver in the oxidation of lipids.
It is a precursor of acetyl-CoA, which is used by cells for the synthesis
of fatty acids and cholesterol. To further investigate if a differential
effect is induced by the paradigm in HD and LD groups, we added this
variable to the model in the following analysis (detailed in Section ).
Differentiation between LD and HD Groups
in Pre- and Post-SIP Serum Samples
A valid discrimination
between LD and HD drinkers was found only for post-SIP samples after
the application of an OPLS-DA model (Figure ). This means that it was not possible to
observe metabolic changes a priori to the SIP procedure,
so it would not be possible to “predict” the behavior
of each rat based on serum metabolic profiles. To obtain a valid model,
we removed serum samples of rats showing a drinking volume between
10 and 20 mL from the model. So, this model tried to maximize differences
between very low drinkers (<10 mL) and very high drinkers (>20
mL).
Figure 5
OPLS-DA (A) score and (B) contribution plots obtained for 1H NMR data of post-SIP samples that were classified as LD
(n = 20) and HD (n = 18). Positive
and negative bars in the contribution plot explain the spectral regions
containing metabolites that discriminate for HD and LD samples, respectively.
These include glutamine (loadings 2.14, 2.46), fatty acids/LDL/VLDL
(loadings 0.86, 0.90, 0.94, 1.26, 1.30, 1.34, 2.02, 2.06, 2.26, 2.30),
3-hydroxybutyrate (HB, loadings 2.32, 2.40, 4.16), choline (loading
3.22), and lactate (1.34, 4.10), which increased in HD drinkers, and
ethanol (loadings 1.18, 3.66), alanine (loading 1.50), glycerol (loadings
3.62, 3.66), and glucose (loadings 5.26, 4.66, 3.90, 3.86, 3.74, 3.46,
3.26), which decreased. Only the samples from very low drinkers (<10
mL) and very high drinkers (>20 mL) were considered. Pareto scaling
was carried out. R2X =
0.68, Q2 = 0.58, p(cv-ANOVA)
= 0.032.
OPLS-DA (A) score and (B) contribution plots obtained for 1H NMR data of post-SIP samples that were classified as LD
(n = 20) and HD (n = 18). Positive
and negative bars in the contribution plot explain the spectral regions
containing metabolites that discriminate for HD and LD samples, respectively.
These include glutamine (loadings 2.14, 2.46), fatty acids/LDL/VLDL
(loadings 0.86, 0.90, 0.94, 1.26, 1.30, 1.34, 2.02, 2.06, 2.26, 2.30),
3-hydroxybutyrate (HB, loadings 2.32, 2.40, 4.16), choline (loading
3.22), and lactate (1.34, 4.10), which increased in HD drinkers, and
ethanol (loadings 1.18, 3.66), alanine (loading 1.50), glycerol (loadings
3.62, 3.66), and glucose (loadings 5.26, 4.66, 3.90, 3.86, 3.74, 3.46,
3.26), which decreased. Only the samples from very low drinkers (<10
mL) and very high drinkers (>20 mL) were considered. Pareto scaling
was carried out. R2X =
0.68, Q2 = 0.58, p(cv-ANOVA)
= 0.032.The blood serum of post-SIP HD
rats specifically showed increased
low-density lipoprotein (LDL)/very low-density lipoprotein (VLDL),
fatty acid (except unsaturated fatty acids), 3-hydroxybutyrate, glutamine,
choline, and lactate levels, accompanied by a decrease in glycerol,
glucose, alanine, and ethanol levels when compared with post-SIP LD
rats. Figure shows
the box-and-whisker plots of normalized integration values of peaks
from these altered metabolites (relative to TSP signal integral) with
an indication of the integration ranges, median quartiles, and extremes.
Figure 6
Box plots
showing the average, median quartiles, and extremes for
specific peak integration values (relative to the TSP peak integral
and normalized to total spectra intensity) for 3-hydroxybutyrate,
glutamine, lactate, choline, LDL/VLDL, and FA levels, except for UFA,
which increased post-SIP for HD rats, and glycerol, alanine, and glucose,
which decreased post-SIP for HD rats when compared with LD rats. All
of these metabolites presented p values of <0.05
using ANOVA analyses followed by the least significant difference
(LSD) post hoc tests in post-SIP.
Box plots
showing the average, median quartiles, and extremes for
specific peak integration values (relative to the TSP peak integral
and normalized to total spectra intensity) for 3-hydroxybutyrate,
glutamine, lactate, choline, LDL/VLDL, and FA levels, except for UFA,
which increased post-SIP for HD rats, and glycerol, alanine, and glucose,
which decreased post-SIP for HD rats when compared with LD rats. All
of these metabolites presented p values of <0.05
using ANOVA analyses followed by the least significant difference
(LSD) post hoc tests in post-SIP.These results suggest that lipid-metabolism-related molecules
(including
total cholesterol (TC) content, glutamine, choline, and glycerol)
might be associated with a compulsive behavior phenotype during SIP.
To further support the observed trends, we conducted the identification
and quantification of fatty acid profiles in serum samples by gas
chromatography with flame ionization detection (GC-FID) (Figure ). The polyunsaturated
arachidonic acid (C20:4n6) was found to be the major fatty acid in
the samples followed by the saturated palmitic acid (C16:0) and by
linoleic acid (C18:2n6) and oleic acid (C18:1n9). HD rats showed an
increase in the saturated palmitic acid (C16:0), the monounsaturated
oleic acid (C18:1n9), and the polyunsaturated linoleic acid (C18:2n6)
compared with LD rats (p < 0.05) and a decrease
in arachidonic acid, the major polyunsaturated fatty acid (PUFA) in
serum samples. As shown in Figure , statistically significant pre-SIP differences between
LDs and HDs exist and remain constant post-SIP. These results agree
well with NMR results that detected an increase in fatty acid/LDL/VLDL
content in HD rats, except for UFA. Interestingly, GC-FID analysis
showed that the total PUFA content was significantly higher in LD
rats compared with HD rats already in pre-SIP samples (p < 0.05).
Figure 7
Fatty acid quantification by GC-FID. Bars with (*) and
(**) revealed
a significant increase and decrease (p < 0.05
by univariate t tests), respectively, in the lipid
content in the serum of HD rats compared with LD rats.
Fatty acid quantification by GC-FID. Bars with (*) and
(**) revealed
a significant increase and decrease (p < 0.05
by univariate t tests), respectively, in the lipid
content in the serum of HD rats compared with LD rats.These results are intriguing because some preclinical studies
have
also found a similar output in compulsive animals: Increased TC, VLDL,
and LDL levels were found in dogs exhibiting tail chasing (a stereotyped
behavior proposed as a valid preclinical model for studying OCD in
animals)[22] in comparison with control subjects,[23,24] whereas decreased glucose serum levels were found in highly compulsive
rats selected by SIP compared with noncompulsive animals.[25] In human studies, OCD patients have been shown
to exhibit higher high-density lipoprotein (HDL) serum levels than
healthy controls.[26] Moreover, Brennan et
al.[27] performed a critical review of 1H magnetic resonance imaging studies on OCD in brain tissues
and concluded that changes in glutamate/glutamine levels were common
among patients versus healthy individuals, although some inconsistencies
have been unraveled. For instance, some studies reported a decrease
whereas others reported an increase in the glutamate-glutamine (Glx)
level. Also, choline was referred to be a crucial biomarker in OCD,
and most studies showed an increase in this metabolite in OCD individuals.Similarly, other neuropsychiatric conditions related to inhibitory
control have been studied regarding metabolic changes. Schwarz et
al.[28] reported significant alterations
of brain tissue free fatty acids and phosphatidylcholine levels in
subjects with schizophrenia and bipolar disorder using a high-throughput
mass spectrometry approach (UPLC–MS) and suggested that lipid
abnormalities may be an intrinsic feature of both schizophrenia and
bipolar disorder. Atmaca et al.[29] observed
decreased serum cholesterol and leptin levels in bipolar disorder
patients, whereas Ozbulut et al.[30] found
decreased serum ghrelin and increased TC levels in euthymic patients
under lithium treatment when compared with controls. In depression,
Kaddurah-Daouk and Krishnan[31] reported
that fatty acids, glycerol, and γ-aminobutyric acid (GABA) were
altered in currently depressed patients when compared with controls.
Also, an increase in the concentration of the ketone 3-hydroxybutyric
acid was found in remitted patients relative to depressed patients.
Furthermore, Nakazato et al.[32] found a
relationship between increased glutamine serum levels and compulsive-like
behavior, as assessed by total and perseverative errors in set-shifting
tasks in subjects recovered from anorexia nervosa, which also is adopted
in the impulsive-compulsive spectrum.It could be argued, however,
that these metabolic effects might
have been induced by diet due to the mere exposure to reward pellets
during SIP sessions. Indeed, obese individuals have been reported
to exhibit poorer behavioral inhibition[18] and a stronger attentional bias toward food[33,34] compared with healthy subjects. Moreover, impulsive behavior seems
to be correlated with a higher consumption of fast food[35] and a higher body mass index (BMI),[36] whereas in preclinical models, exposure to highly
palatable, fat-rich diets has been shown to induce compulsive food-seeking
behavior[37−39] and to affect marble burying behavior.[40−42] Thus to explore that possibility, we planned and carried out an
additional experiment where a cohort of animals were subjected to
19 sessions of exposure to reward pellets, as described in the Methods section.
Differentiation
between Pre-Pellet and Post-Pellet
Serum Samples
A PLS-DA model was generated to investigate
the metabolic differences between serum samples collected before and
after the control diet experiment. A valid discrimination between
pre- and post-pellet groups was found in the score plot (Figure A), meaning that
the reward pellets had effects on the serum metabolic composition.
The loading plot (Figure B) highlights the most significant variables of the model
by describing the influence and relation among the variables in the
model plane. Therefore, it is possible to conclude that the peaks
in spectral zones should be significantly increased (upper right loadings)
and decreased (bottom left loadings) in the blood serum due to the
exposure to reward pellets in this control experiment (VIP values
>1) and also due to a physiological metabolic evolution over time.
An increase in creatine, citrate, glucose, lysine, glutamine/glutamate,
acetate, and PUFAs was detected in the blood serum after such exposure.
The spectral zones in the bottom left of the loading plot referring
to the metabolites that decrease in post-pellet serum include choline
and other spectral regions that mostly correspond to noise and were
not relevant for analyses, so these were not considered.
Figure 8
(A) PLS-DA
score plot obtained for 1H NMR data of samples
before (n = 20) and after (n = 20)
changing the diet to reward pellets (pre- and post-pellet, respectively).
(B) PLS-DA loading plot revealing the most significant metabolites
for discrimination (with VIP values >1), which correspond to creatine
(loadings 3.06, 3.94), glucose (loadings 5.26, 3.94, 3.78, 3.74, 3.56,
3.50, 3.26), PUFA (loading 2.78), lysine (loadings 1.50, 1.74), acetate
(loading 1.94), formate (loading 8.46), and glutamine/glutamate (loadings
2.14, 2.46, 2.36), which increased in post-pellet samples, and choline
(loadings 3.22), which decreased. Unit-variance scaling was carried
out. R2X = 0.65, Q2 = 0.90, p(cv-ANOVA) = 6.5
× 10–9. The model was validated by a permutation
test (with 100 permutations).
(A) PLS-DA
score plot obtained for 1H NMR data of samples
before (n = 20) and after (n = 20)
changing the diet to reward pellets (pre- and post-pellet, respectively).
(B) PLS-DA loading plot revealing the most significant metabolites
for discrimination (with VIP values >1), which correspond to creatine
(loadings 3.06, 3.94), glucose (loadings 5.26, 3.94, 3.78, 3.74, 3.56,
3.50, 3.26), PUFA (loading 2.78), lysine (loadings 1.50, 1.74), acetate
(loading 1.94), formate (loading 8.46), and glutamine/glutamate (loadings
2.14, 2.46, 2.36), which increased in post-pellet samples, and choline
(loadings 3.22), which decreased. Unit-variance scaling was carried
out. R2X = 0.65, Q2 = 0.90, p(cv-ANOVA) = 6.5
× 10–9. The model was validated by a permutation
test (with 100 permutations).As in the previous set of experiments, the lipid profile of the
pellets was investigated and quantified by GC-FID (Table S2). The reward pellets during the SIP experiment showed
a 2.3-fold increase in fatty acid content, including on PUFAs. Because
the model was not able to discriminate between HDs and LDs either
pre- or post-exposure to reward pellets, it is plausible to assume
that such alterations affected both groups equally, thus pointing
to the idea that the SIP paradigm, and not the diet, is responsible
for the metabolic alterations observed in the vulnerable subjects,
the HD group. There are several underlying mechanisms that should
be investigated in the future regarding the metabolic alterations
observed in the compulsive-drinking HD group selected by SIP, for
example, the possible role of an altered vasopressin, a hormone implicated
in the metabolic syndrome, that drives fat production as a mechanism
for storing metabolic water.[43] Furthermore,
the relevance of gut microbiota dysregulation in different neuropsychopathological
disorders[44−46] should be considered in the metabolic alterations
observed in compulsive HD rats. In this sense, in our laboratory,
we have demonstrated that compulsive HD rats showed a lower bacterial
diversity than LD rats, irrespective of the diet.[47] However, the same study also demonstrated that the administration
of a tryptophan-depleted diet reduced bacterial evenness and showed
a highly functionally organized community in the compulsive HD rats
selected by SIP. This points toward a bacterial community that is
fragile to external changes due to the dominance of a low number of
species in compulsive HD rats compared with noncompulsive LD rats.The dramatic effect found in the present work adds evidence not
only to the stressful properties of intermittent reinforcement in
SIP inducing compulsive behavior but also to severe physiological
effects, such as increased corticosterone levels,[25] increased amygdaloid and decreased hippocampal volume,[15] and increased dendritic spinal density in the
dorsal striatum.[48] In this sense, the aforementioned
finding of increased glutamine levels in HD in the present study is
not surprising given its major role in the brain as the precursor
of glutamate, which is a key factor regarding neuroplasticity[49,50] and one of the altered mechanisms[51] and
putative therapeutic targets[52] in compulsive
drinking in SIP.
Conclusions
The
present study has investigated the metabolomic profile by means
of NMR of high- and low-compulsive rats selected by SIP as a potential
tool for identifying critical biomarkers in vulnerable subjects. We
found that although SIP itself induced a change in the metabolomic
profile, it affected the HD animals differently, which showed a hyperlipidemic,
hypoglycemic, and hypoglutaminergic profile, compared with the LD
animals, in line with the literature regarding both preclinical models
and human patients in OCD and related disorders. Moreover, mere exposure
to reward pellets did not result in a valid model for predicting the
phenotypic profile based on metabolomics, thus leading us to discard
an effect due to diet alone. Our data add significant evidence to
a crucial topic in basic neuroscience and potentially clinical fields;
however, future studies are ongoing in our laboratories to unscramble
this complex phenomenon and to further characterize the putative role
of metabolism in the triggering and early identification of latent
vulnerabilities. In addition, the putative impact of a high-fat diet
on inhibitory control deficit and the potential use of metabolomic
biomarkers in the early diagnose of compulsive spectrum disorders
are envisaged as well.
Authors: K R Magnusson; L Hauck; B M Jeffrey; V Elias; A Humphrey; R Nath; A Perrone; L E Bermudez Journal: Neuroscience Date: 2015-05-14 Impact factor: 3.590
Authors: Júlia Ariana Souza Gomes; Marina C Oliveira; Pedro Henrique Gobira; Grazielle C Silva; Anna Paula Marçal; Giovanni Freitas Gomes; Carolina Zaniboni Ferrari; Virginia Soares Lemos; Antonio Carlos Pinheiro de Oliveira; Luciene Bruno Vieira; Adaliene V M Ferreira; Daniele C Aguiar Journal: Nitric Oxide Date: 2018-08-17 Impact factor: 4.427
Authors: Isabella M Scheepers; John F Cryan; Thomaz F S Bastiaanssen; Kieran Rea; Gerard Clarke; Heather B Jaspan; Brian H Harvey; Sian M J Hemmings; Leonard Santana; Rencia van der Sluis; Stefanie Malan-Müller; De Wet Wolmarans Journal: Eur J Neurosci Date: 2019-11-21 Impact factor: 3.386